Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1374991rdf:typepubmed:Citationlld:pubmed
pubmed-article:1374991lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C0085669lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C1517806lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C1518453lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C1264633lld:lifeskim
pubmed-article:1374991lifeskim:mentionsumls-concept:C0812425lld:lifeskim
pubmed-article:1374991pubmed:issue1-2lld:pubmed
pubmed-article:1374991pubmed:dateCreated1992-6-18lld:pubmed
pubmed-article:1374991pubmed:abstractTextNucleolar organizer regions (NORs) are loops of DNA which transcribes to ribosomal RNA. The NOR-related protein becomes visible in nucleus by a silver-staining technique under a light microscope, and it has been named argyrophilic protein of NOR (Ag-NOR). In various malignancies, the correlation between the proliferation potential of tumor cells or histological grade and the number of Ag-NORs has been reported. In this study, we investigated the Ag-NOR of acute leukemic cells and its relation to the in vivo proportion of bone marrow leukemic cells in DNA synthetic phase. The number of Ag-NORs in bone marrow leukemic cells was more than that in peripheral blood (means values 2.78 and 2.48, respectively, p less than 0.01). This result shows that the number of Ag-NORs reflects the vigorous proliferative potential of bone marrow leukemic cells. However, no significant correlation was obtained between the number of Ag-NORs and the bromodeoxyuridine-labeling indices (r = 0.2064). These results suggest that Ag-NOR might be one of the markers for cellular proliferation in leukemia, while DNA synthesis of leukemic cells do not seem to be directly related to Ag-NOR. In order to clarify the role of Ag-NOR in leukemia, further studies are needed.lld:pubmed
pubmed-article:1374991pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374991pubmed:languageenglld:pubmed
pubmed-article:1374991pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374991pubmed:citationSubsetIMlld:pubmed
pubmed-article:1374991pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374991pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1374991pubmed:statusMEDLINElld:pubmed
pubmed-article:1374991pubmed:issn0001-5792lld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:KobayashiKKlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:MatsudaTTlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:NakamuraSSlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:KannoMMlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:YoshidaTTlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:TakedaYYlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:OhtakeSSlld:pubmed
pubmed-article:1374991pubmed:authorpubmed-author:OkabeYYlld:pubmed
pubmed-article:1374991pubmed:issnTypePrintlld:pubmed
pubmed-article:1374991pubmed:volume87lld:pubmed
pubmed-article:1374991pubmed:ownerNLMlld:pubmed
pubmed-article:1374991pubmed:authorsCompleteYlld:pubmed
pubmed-article:1374991pubmed:pagination6-10lld:pubmed
pubmed-article:1374991pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:meshHeadingpubmed-meshheading:1374991-...lld:pubmed
pubmed-article:1374991pubmed:year1992lld:pubmed
pubmed-article:1374991pubmed:articleTitleArgyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells.lld:pubmed
pubmed-article:1374991pubmed:affiliationThird Department of Medicine, Kanazawa University School of Medicine, Japan.lld:pubmed
pubmed-article:1374991pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374991lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1374991lld:pubmed